The growing obesity medication landscape includes GLP-1 agonists like Wegovy and Ozempic, combination drugs like Contrave and Qsymia, and newer drugs like Zepbound, which can lead to up to 20% weight loss
As a GLP-1 receptor agonist, it mimics a naturally occurring gut hormone that slows down how quickly food leaves your stomach, signals areas of the brain that regulate appetite, and helps your pancreas release insulin more effectively
Richard Siegel, co-director of the Diabetes and Lipid Center at Tufts Medical Center and Endocrinologist at Tufts Medicine Weight and Wellness CenterStoneham
Take our AI quiz to discover the best supplement tailored to your individual needs and experience the Cymbiotika difference
By embracing a comprehensive approach that combines GLP-1 therapies with sustainable lifestyle changes, you can optimize your health, achieve your goals, and set the stage for long-term success
Comparison with Oral Semaglutide Pharmacokinetics Pharmacokinetic Summary Orforglipron's ~79% oral bioavailability, lack of food effect, and no fasting requirements represent a transformative improvement over oral semaglutide's 20%) may still benefit from injectable tirzepatide or combination approaches